Firefly Neuroscience, Inc. (AIFF) Financial Ratios
5 years of historical data (2020–2024) · Technology · Software - Application
EV/EBITDA
N/A
—
5yr avg: 804.40
P/FCF
N/A
—
5yr avg: 954.38
P/B Ratio
↑
N/A
—
5yr avg: 289.13
ROE
↓
N/A
—
5yr avg: -1181.2%
30Y Low26%·High26%
Debt/EBITDA
N/A
—
5yr avg: 1.17
30Y Low1.2·High1.2
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
AIFF Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Firefly Neuroscience, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Market Cap | $27M | $17M | $40M | $113M | $1.2B | $342M |
| Enterprise Value | $26M | $16M | $38M | $113M | $1.2B | $341M |
| P/E Ratio → | -1.21 | — | — | — | — | 828.57 |
| P/S Ratio | 254.01 | 160.64 | 80.12 | — | 36522.88 | 24.62 |
| P/B Ratio | — | — | 366.06 | — | — | 212.20 |
| P/FCF | — | — | — | — | — | 954.38 |
| P/OCF | — | — | — | — | — | 808.85 |
P/E links to full P/E history page with 30-year chart
AIFF EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| EV / Revenue | — | 150.30 | 75.82 | — | 36558.35 | 24.53 |
| EV / EBITDA | — | — | — | — | — | 804.40 |
| EV / EBIT | — | — | — | — | — | 824.89 |
| EV / FCF | — | — | — | — | — | 950.58 |
AIFF Profitability
Margins and return-on-capital ratios measuring operating efficiency
Firefly Neuroscience, Inc. earns an operating margin of -8500.0%. Operating margins have compressed from -618.1% to -8500.0% over the past 3 years, signaling potential cost pressures or competitive headwinds.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Gross Margin | 38.0% | 38.0% | 100.0% | — | 100.0% | 15.9% |
| Operating Margin | -8500.0% | -8500.0% | -618.1% | — | -14543.8% | 3.0% |
| Net Profit Margin | -9685.2% | -9685.2% | -522.7% | — | -13690.6% | 3.0% |
Return on Capital
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| ROE | — | — | -2388.1% | — | — | 25.6% |
| ROA | -288.9% | -288.9% | -187.5% | -696.5% | -185.4% | 11.0% |
| ROIC | — | — | — | — | — | — |
| ROCE | — | — | -2823.9% | — | — | 20.9% |
AIFF Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $2M exceeds total debt of $694000, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | 0.31 |
| Debt / EBITDA | — | — | — | — | — | 1.17 |
| Net Debt / Equity | — | — | -19.66 | — | — | -0.84 |
| Net Debt / EBITDA | — | — | — | — | — | -3.21 |
| Debt / FCF | — | — | — | — | — | -3.80 |
| Interest Coverage | -133.04 | -133.04 | -171.00 | -5.80 | -34.47 | — |
Net cash position: cash ($2M) exceeds total debt ($694000)
AIFF Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.53x is below 1.0, meaning current liabilities exceed current assets. The current ratio has improved from 0.04x to 0.53x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Current Ratio | 0.53 | 0.53 | 0.89 | 0.04 | 0.18 | 1.86 |
| Quick Ratio | 0.53 | 0.53 | 0.89 | 0.04 | 0.18 | 1.86 |
| Cash Ratio | 0.36 | 0.36 | 0.85 | 0.03 | 0.16 | 1.03 |
| Asset Turnover | — | 0.02 | 0.19 | — | 0.03 | 3.68 |
| Inventory Turnover | — | — | — | — | — | — |
| Days Sales Outstanding | — | 408.94 | 61.57 | — | 467.66 | 37.86 |
AIFF Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Firefly Neuroscience, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | 0.1% |
| FCF Yield | — | — | — | — | — | 0.1% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $7M | $8M | $8M | $8M | $8M |
Peer Comparison
Compare AIFF with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 AIFFYou | $27M | -1.2 | — | — | 38.0% | -8500.0% | — | — | — |
 MBRX | $29M | -0.1 | — | — | — | — | -319.8% | -441.5% | — |
 NRXP | $84M | -2.3 | — | — | — | -1324.4% | — | — | — |
 BTAI | $3M | -0.1 | — | — | 5.4% | -2967.6% | — | — | — |
 NVAX | $2B | 3.7 | 2.6 | — | 93.7% | 50.1% | — | — | 0.4 |
 AXSM | $11B | -60.5 | — | — | 92.6% | -26.5% | -252.1% | -1906.7% | — |
 INVA | $2B | 6.8 | 8.0 | 9.8 | 72.3% | 38.5% | 29.1% | 14.2% | 1.3 |
 SAVA | $94M | -3.8 | — | — | — | — | -17.2% | -634.1% | — |
 PRAX | $8B | -25.1 | — | — | — | — | -45.8% | -65.0% | — |
 NVCR | $2B | -13.5 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 MASI | $9B | -63.7 | 27.7 | 47.2 | 61.9% | 20.5% | -17.1% | 16.5% | 1.6 |
| Technology Median | — | 27.5 | 17.4 | 19.8 | 48.6% | -0.5% | 2.4% | 2.9% | 2.9 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 5 years · Updated daily
See AIFF's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AIFF Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AIFF vs MBRX
Side-by-side business, growth, and profitability comparison vs Moleculin Biotech, Inc..
Start ComparisonAIFF — Frequently Asked Questions
Quick answers to the most common questions about buying AIFF stock.
What is Firefly Neuroscience, Inc.'s P/E ratio?
Firefly Neuroscience, Inc.'s current P/E ratio is -1.2x. This places it at the 50th percentile of its historical range.
Is AIFF stock overvalued?
Based on historical data, Firefly Neuroscience, Inc. is trading at a P/E of -1.2x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Firefly Neuroscience, Inc.'s profit margins?
Firefly Neuroscience, Inc. has 38.0% gross margin and -8500.0% operating margin.